Minireviews
Copyright ©2014 Baishideng Publishing Group Inc.
World J Clin Cases. Dec 16, 2014; 2(12): 866-872
Published online Dec 16, 2014. doi: 10.12998/wjcc.v2.i12.866
Table 1 Risk factors of malignant transformation
Female gender
Long duration of leukoplakia
Leukoplakia in non-smokers
Location on the tongue and/or floor of the mouth
Size > 200 mm2
Non-homogenous type
Presence of epithelial dysplasia
Table 2 Miscellaneous treatment regimens for oral lichen planus
Topical treatmentsSystemic treatmentsSurgery
Corticosteroids (triamcinolone, fluocinolone acetonide, fluocinonide, clobetasol, fluticasone propionate, betamethasone sodium phosphate, mometasone furoate) Cyclosporin Tacrolimus Pimekrolimus Rapamycin (sirolimus) Retinoids (tretinoin, isotretinoin) Aloe vera Hyaluronic acid 0.2% gelCorticosteroids Acitretin Azathioprine Basiliximab Cyclosporin Dapsone Eiconol Enoxaparin Glycyrrhizin Hydroxychloroquine Interferon alpha Levamisole Mycophenolate mofetil Thalidomide Tetracycline Mesalazine Phenytoin GriseofulvinResection Cryotherapy Lasers (CO2, excimer laser)
Table 3 Clinical and functional staging
Clinical stageFunctional stage
Faucial bands onlyMouth opening ≥ 20 mm
Faucial and buccal bandsMouth opening 11-19 mm
Faucial, buccal, and labial bandsMouth opening ≤ 10 mm